World
Pancreatic cancer drug Daraxonrasib gets approval fromFDA: All you need to know
FDA officials gave expedited approval to daraxonrasib, which blocks a mutated protein that fuels tumor growth
This story summarizes reporting from Hindustan Times. Read the original for full context. Wire items stay in our news sitemap for seven days. Editorial policy.
Read full story on Hindustan Times →Hindustan Times27 Aug 2026, 12:08 amUpdated 3d ago1 min readWorldWorld
World — Hindustan Times
